Innovita Biological Technology Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100005Q14
CNY
36.49
0.46 (1.28%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Innovita Biological Technology Co., Ltd.

Why is Innovita Biological Technology Co., Ltd. ?

1
The company has declared negative results for the last 2 consecutive quarters
  • The company has declared negative results in Dec 24 after 5 consecutive negative quarters
  • NET SALES(HY) At CNY 145.6 MM has Grown at -27.32%
  • NET PROFIT(HY) At CNY 20.05 MM has Grown at -46.72%
  • OPERATING CASH FLOW(Y) Lowest at CNY 106.63 MM
2
Underperformed the market in the last 1 year
  • The stock has generated a return of 6.66% in the last 1 year, much lower than market (China Shanghai Composite) returns of 22.49%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Innovita Biological Technology Co., Ltd. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Innovita Biological Technology Co., Ltd.
0.44%
-0.27
39.79%
China Shanghai Composite
16.01%
1.58
14.20%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
16.59%
EBIT Growth (5y)
73.58%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.96
Sales to Capital Employed (avg)
0.27
Tax Ratio
8.78%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
128.44%
ROE (avg)
9.63%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
27
Industry P/E
Price to Book Value
2.07
EV to EBIT
17.02
EV to EBITDA
13.76
EV to Capital Employed
13.51
EV to Sales
4.96
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
79.37%
ROE (Latest)
7.76%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Bullish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

6What is working for the Company
PRE-TAX PROFIT(Q)

At CNY 13.57 MM has Grown at 260.65%

NET PROFIT(Q)

At CNY 14.86 MM has Grown at 2,901.29%

-27What is not working for the Company
NET SALES(HY)

At CNY 145.6 MM has Grown at -27.32%

NET PROFIT(HY)

At CNY 20.05 MM has Grown at -46.72%

OPERATING CASH FLOW(Y)

Lowest at CNY 106.63 MM

INTEREST(9M)

At CNY 0.08 MM has Grown at 7.15%

ROCE(HY)

Lowest at 7.22%

RAW MATERIAL COST(Y)

Grown by 101.4% (YoY

DEBT-EQUITY RATIO (HY)

Highest at 0 %

INVENTORY TURNOVER RATIO(HY)

Lowest at 0 times

DEBTORS TURNOVER RATIO(HY)

Lowest at 0 times

EPS(Q)

Lowest at CNY 0

Here's what is working for Innovita Biological Technology Co., Ltd.

Pre-Tax Profit
At CNY 13.57 MM has Grown at 260.65%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Net Profit
At CNY 14.86 MM has Grown at 2,901.29%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (CNY MM)

Here's what is not working for Innovita Biological Technology Co., Ltd.

Net Sales
At CNY 145.6 MM has Grown at -27.32%
Year on Year (YoY)
MOJO Watch
Near term sales trend is very negative

Net Sales (CNY MM)

Interest
At CNY 0.08 MM has Grown at 7.15%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Operating Cash Flow
Lowest at CNY 106.63 MM
in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

EPS
Lowest at CNY 0
in the last five periods
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (CNY)

Debt-Equity Ratio
Highest at 0 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Inventory Turnover Ratio
Lowest at 0 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio
Lowest at 0 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost
Grown by 101.4% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales